ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Extendicare Inc

Extendicare Inc (EXE)

7.38
0.00
(0.00%)
Closed July 22 4:12PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
7.38
Bid
7.40
Ask
7.40
Volume
-
0.00 Day's Range 0.00
5.75 52 Week Range 8.03
Market Cap
Previous Close
7.38
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
125,441
Shares Outstanding
11,778,000
Dividend Yield
-
PE Ratio
2.56
Earnings Per Share (EPS)
2.89
Revenue
1.3B
Net Profit
33.98M

About Extendicare Inc

Sector
Nursng,personal Care Fac,nec
Industry
Real Estate Investment Trust
Headquarters
Markham, Ontario, Can
Founded
1993
Extendicare Inc is listed in the Nursng,personal Care Fac sector of the Toronto Stock Exchange with ticker EXE. The last closing price for Extendicare was $7.38. Over the last year, Extendicare shares have traded in a share price range of $ 5.75 to $ 8.03.

Extendicare currently has 11,778,000 shares outstanding. The market capitalization of Extendicare is $86.92 million. Extendicare has a price to earnings ratio (PE ratio) of 2.56.

EXE Latest News

Extendicare Announces July 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

Extendicare Announces Timing of 2024 Second Quarter Results and Conference Call

MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second...

Extendicare Announces Renewal of Normal Course Issuer Bid

MARKHAM, Ontario, June 26, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the...

Extendicare Announces June 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders

MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of...

Extendicare Announces 2024 First Quarter Results

MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2024. Results are...

Extendicare Announces April 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

Extendicare Announces Timing of 2024 First Quarter Results and Conference Call

MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first...

Extendicare ouvre les marchés

Extendicare ouvre les marchés Canada NewsWire TORONTO, le 15 févr. 2024 TORONTO, le 15 févr. 2024 /CNW/ - Le Dr Michael Guerriere, président et chef de la direction, Extendicare Inc. («...

Extendicare Opens the Market

Extendicare Opens the Market Canada NewsWire TORONTO, Feb. 15, 2024 TORONTO, Feb. 15, 2024 /CNW/ - Dr. Michael Guerriere, President and Chief Executive Officer, Extendicare Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.131.793103448287.257.47.2676257.30354235CS
40.121.652892561987.267.47.1735837.26684022CS
120.070.9575923392617.318.037.11254417.5063716CS
260.212.928870292897.178.036.631256137.3581273CS
52-0.02-0.270270270277.48.035.751280836.98476421CS
156-1.2-13.9860139868.588.585.751578347.11941912CS
260-1.23-14.28571428578.619.64.92135046.89171907CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 1.2701
(84.39%)
18.97M
NCPLNetcapital Inc
$ 0.1418
(36.35%)
36.24M
SERVServe Robotics Inc
$ 10.25
(35.76%)
25.92M
RRRichtech Robotics Inc
$ 1.83
(24.49%)
13.97M
NUKKNukkleus Inc
$ 0.3964
(23.88%)
1.89M
HUBCWHub Cyber Security Ltd
$ 0.0121
(-47.39%)
1.67k
XCURExicure Inc
$ 0.40
(-25.25%)
494.41k
SNTGSentage Holdings Inc
$ 2.03
(-18.15%)
27.59k
PIRSPieris Pharmaceuticals Inc
$ 6.00
(-17.24%)
11
BCBPBCB Bancorp Inc
$ 10.20
(-16.53%)
629
NCPLNetcapital Inc
$ 0.1418
(36.35%)
36.24M
SERVServe Robotics Inc
$ 10.25
(35.76%)
25.92M
MIRAMIRA Pharmaceuticals Inc
$ 1.2701
(84.39%)
18.97M
RRRichtech Robotics Inc
$ 1.83
(24.49%)
13.97M
MAXNMaxeon Solar Technologies Ltd
$ 0.2272
(5.38%)
10.31M

EXE Discussion

View Posts
MisterEC MisterEC 9 years ago
I have traded this a number of times. Back in at 5.90 this morning. Below is a statement from the Motley Fool analyst I heard about this stock from. Unfortunate I lost track of his coverage and all my trades were done after this was released, and before I read this, except when I got back in today.

Extendicare (NASDAQOTH:EXETF) -- This was a truly unfortunate experience, as management just worked over
shareholders in a terrible way. It ran the REIT's American business into the ground and then sold it at a low point
(very much like buy high/sell low investors). The conference call announcing the deal was unbelievable, and you
could hear the anxiety in the CEO's voice as he delivered the news and parried questions from analysts. With only
a little cash going back to shareholders in the form of a stock buyback -- surely after some investors twisted
management's arm -- shareholders were right to dump the stock. It would be much more accretive to buy back stock
at these prices, but management wants to expand the business. That would be poor capital allocation.
James Royal
(TMFRoyal)
Jan 23, 2015 at 10:06AM
👍️0
clotter2 clotter2 9 years ago
Extendicare breaking resistance level. This should get good from here . LONG+
👍️0
clotter2 clotter2 9 years ago
I want to talk $EXETF $TROV.. Health-care, Biopharm, and retail...
👍️0
toddski toddski 9 years ago
Extendicare (TSE:EXE) had its price target upped by CIBC from C$7.50 to C$8.00 in a research note issued to investors on Friday. The firm currently has a sector perform rating on the stock.

http://www.mideasttime.com/extendicare-given-new-c8-00-price-target-at-cibc-exe/362393/
👍️0
toddski toddski 10 years ago
Extendicare announced 10% share buyback program:

http://finance.yahoo.com/news/extendicare-announces-intention-issue-normal-223000319.html
👍️0

Your Recent History

Delayed Upgrade Clock